Stockreport

Gilead Strengthens Inflammation Portfolio With Ouro Medicines Deal [Yahoo! Finance]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF The deal brings a clinical-stage bispecific T-cell engager, OM336 (gamgertamig), into Gilead's inflammation portfolio, adding a potentially first-in-class approach aime [Read more]